After advanced ovarian cancer responds to chemotherapy, some patients may have another decision to make. Here's why doctors ...

Ovarian cancer has a particularly poor survival rate. Only one in two women will live five years beyond their diagnosis.

Medically reviewed by Renita White, MD Key Takeaways Ovarian cancer treatment often includes surgery and chemotherapy, but ...

How Does Zejula Work in Advanced Ovarian Cancer? In platinum-based chemotherapy, the platinum in the medicine binds to the genetic material (DNA) of cancer cells. This damages the cancer cells and ...

Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy. The low response rates underscore a significant clinical need to ...

CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

Please provide your email address to receive an email when new articles are posted on . The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ...

From today, the Australian government will expand Pharmaceutical Benefits Scheme (PBS) access to the drug Keytruda for three ...

Research, headed by teams at Trinity College Dublin and University College Dublin, has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s ...

Kate Ping thought she was just stressed out. A nurse practitioner's surprising recommendation led to a shocking diagnosis.